LISURIDE IN PARKINSON DISEASE - EFFICACY OF LISURIDE COMPARED TO LEVODOPA

被引：38

作者：

LIEBERMAN, A

GOLDSTEIN, M

NEOPHYTIDES, A

KUPERSMITH, M

LEIBOWITZ, M

ZASORIN, N

WALKER, R

KLEINBERG, D

机构：

[1] NYU, SCH MED, DEPT NEUROL, NEW YORK, NY 10003 USA

[2] NYU, SCH MED, DEPT PSYCHIAT, NEW YORK, NY 10003 USA

[3] NYU, SCH MED, DEPT MED, NEW YORK, NY 10003 USA

来源：

NEUROLOGY | 1981年 / 31卷 / 08期

关键词：

D O I：

10.1212/WNL.31.8.961

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：961 / 965

页数：5

共 34 条

[1] DEVELOPMENTS IN PHARMACOLOGY AND THERAPEUTICS OF PARKINSONISM [J].

CALNE, DB .

ANNALS OF NEUROLOGY, 1977, 1 (02) :111-119

[2]

CALNE DB, 1978, LANCET, V1, P735

[3] L-DOPA TREATMENT IN PARKINSONS DISEASE - EFFECT ON DOPAMINE AND RELATED SUBSTANCES IN DISCRETE BRAIN REGIONS [J].

DAVIDSON, L ;

LLOYD, K ;

DANKOVA, J ;

HORNYKIEWICZ, O .

EXPERIENTIA, 1971, 27 (09) :1048-+

[4] IS L-DOPA DRUG HOLIDAY USEFUL [J].

DIRENFELD, LK ;

FELDMAN, RG ;

ALEXANDER, MP ;

KELLYHAYES, M .

NEUROLOGY, 1980, 30 (07) :785-788

[5] EFFECTS OF L-DOPA METABOLITES AT A DOPAMINE RECEPTOR SUGGEST A BASIS FOR ON-OFF EFFECT IN PARKINSONS-DISEASE [J].

DOUGAN, D ;

WADE, D ;

MEARRICK, P .

NATURE, 1975, 254 (5495) :70-72

[6] CONSIDERATIONS IN MANAGEMENT OF PARKINSONISM [J].

FAHN, S ;

CALNE, DB .

NEUROLOGY, 1978, 28 (01) :5-7

[7] ROLE OF BROMOCRIPTINE IN THE TREATMENT OF PARKINSONISM [J].

FAHN, S ;

COTE, LJ ;

SNIDER, SR ;

BARRETT, RE ;

ISGREEN, WP .

NEUROLOGY, 1979, 29 (08) :1077-1083

[8]

Goldstein M, 1980, Adv Biochem Psychopharmacol, V23, P75

[9]

GOLDSTEIN M, 1979, DOPAMINERGIC ERGOT D, P253

[10] PARTIAL LESIONS OF THE DOPAMINERGIC NIGROSTRIATAL SYSTEM IN RAT-BRAIN - BIOCHEMICAL-CHARACTERIZATION [J].

HEFTI, F ;

MELAMED, E ;

WURTMAN, RJ .

BRAIN RESEARCH, 1980, 195 (01) :123-137

← 1 2 3 4 →